Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/26 07:31 | 4/1/26 | CGEN | Health | BioPrd | Biological Products, (No Diag | Levine Zurit | O | SVP,Busi | 4 | M.d | 45 | 1.46 | 0 | 31 | 29 | D | ||||||||||||||||
4/3/26 07:31 | 4/1/26 | CGEN | Health | BioPrd | Biological Products, (No Diag | Levine Zurit | O | SVP,Busi | 4 | S.d | -45 | 1.46 | 0 | -31 | 29 | D | ||||||||||||||||
4/3/26 07:29 | 4/1/26 | CGEN | Health | BioPrd | Biological Products, (No Diag | Ophir Eran | DO | P,CEO | 2 | M.d | 17 | 1.52 | 0 | 11 | 999% | 11 | D | |||||||||||||||
4/3/26 07:29 | 4/1/26 | CGEN | Health | BioPrd | Biological Products, (No Diag | Ophir Eran | DO | P,CEO | 2 | S.d | -17 | 1.52 | 0 | -11 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |